MedTrace Logo

Does the Type of Ventilation Affect the Risk for Infections After Hip Replacements?

NCT05932823 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110000

Last updated 2023-07-06

No results posted yet for this study

Summary

Background: During hip replacement surgery, there is a risk that bacteria in the operating room can cause an infection. To try and reduce this risk, some operating rooms use a special system called laminar airflow (LAF), which reduces the number of bacteria in the air. However, it's not clear if LAF is better than the older system, called turbulent airflow (TAF), for preventing infections.

Aim: The aim of this study is to compare the two airflow systems and see if LAF is better at preventing infections after hip replacement surgery.

Methods: Information from a database containing all hip replacement surgeries done in Denmark between 2010 and 2020 is examined. The number of infections that occur in surgeries done with LAF, which reduces the number of bacteria in the air during surgery, is compared to the number of infections that occur in surgeries done with TAF. To make the results more credible, the data from the hip register was combined with data from the bacterial cultures taken during surgery.

Use and relevance: Infections after hip replacement surgery can be very serious and expensive to treat. Hospitals need to choose the best airflow system to help prevent these infections. This study is important because it gives more accurate information about which system is better at preventing infections and can help hospitals make better choices when they are designing or renovating operating rooms.

Conditions

  • Hip Prosthesis Infection

Interventions

OTHER

Laminary airflow

A ventilation system that reduces the number of bacteria in the air compared to conventional ventilation.

Sponsors & Collaborators

  • University Hospital Bispebjerg and Frederiksberg, Søren Overgaard, Professor, Ph.D.

    collaborator UNKNOWN

  • University Hospital Bispebjerg and Frederiksberg, Espen Jimenez Solem, Associate professor, Ph.D.

    collaborator UNKNOWN

  • University Hospital Bispebjerg and Frederiksberg, Anne Helms Andreasen, Statistician

    collaborator UNKNOWN

  • University Hospital Bispebjerg and Frederiksberg, Cathrine Uhrbrand Fox Maule, Data scientist

    collaborator UNKNOWN

  • University Hospital Bispebjerg and Frederiksberg, Janne Pedersen, Statistician, PhD, Associate Professor

    collaborator UNKNOWN

  • University Hospital Bispebjerg and Frederiksberg

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-01
Primary Completion
2021-12-31
Completion
2021-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05932823 on ClinicalTrials.gov